Company intelligence / Profile preview

Sichuan Jinjiang Electronic Medical Device Technology

Ownership: Private
Development stage: Commercial

Overview

The company's pulsed field ablation catheter/system is the first such product approved by China's NMPA to treat atrial fibrillation. Early clinical results show favorable feasibility and safety in treating AVNRT/paroxysmal supraventricular tachycardia.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

C.R. Bard Inc.

Beyond the preview

Go deeper on Sichuan Jinjiang Electronic Medical Device Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sichuan Jinjiang Electronic Medical Device Technology.

Explore the full profile